Skip to content

Fish oil supplementation in pregnancy to reduce allergies in early childhood

Early childhood follow up of a randomised controlled trial to compare maternal docosahexanoeic acid (DHA) rich tuna oil versus vegetable oil supplementation in pregnancy on child allergic disease outcomes.

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12610000735055
Acronym
DHAllergy
Enrollment
706
Registered
2010-09-03
Start date
2006-03-20
Completion date
2008-05-08
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

DHA is an omega-3 fat found in fish and fish oils and is thought to effect an infant's developing immune system. While in the womb, the baby is supplied with DHA from the mothers circulation. This study will help determine whether increasing the amount of DHA in the diet of pregnant women reduces allergies in their children.

Interventions

3 x 500mg high-DHA rich tuna oil capsules per day taken from 18-21 weeks gestation until birth

Sponsors

Women's and Children's Health Research Institute
Lead SponsorGovernment body

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
0 to No maximum
Healthy volunteers
Yes

Inclusion criteria

Child to have a family history of medically diagnosed allergic disease (eczema, asthma, allergic rhinitis): singleton pregnancy less than 18-21 weeks gestation with no known fetal abnormality: mothers not to have had documented history of alcohol or drug abuse: no participation in other clinical trials with fatty acid intervention.

Exclusion criteria

Maternal bleeding disorders where DHA tuna oil is contraindicated

Outcome results

None listed

Source: ANZCTR · Data processed: Mar 27, 2026